These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8003524)

  • 1. Stabilized structure of the presynaptic (Y2) receptor-specific neuropeptide Y analog N-acetyl[Leu-28,Leu-31]NPY(24-36).
    Barden JA; Cuthbertson RM; Potter EK; Selbie LA; Tseng A
    Biochim Biophys Acta; 1994 Jun; 1206(2):191-6. PubMed ID: 8003524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the presynaptic (Y2) receptor-specific neuropeptide Y analog ANA-NPY.
    Barden JA; Cuthbertson RM; Potter EK
    Biochim Biophys Acta; 1995 Jul; 1250(1):83-9. PubMed ID: 7612657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of neuropeptide tyrosine 13-36, a Y2 receptor agonist, as determined by NMR.
    Labelle M; St-Pierre S; Savard R; Boulanger Y
    Eur J Biochem; 1997 Jun; 246(3):780-5. PubMed ID: 9219539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of prejunctional receptor binding analog of human neuropeptide Y dimer ANA-NPY.
    Barden JA
    Biochem Biophys Res Commun; 1995 Oct; 215(1):264-71. PubMed ID: 7575600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helical structure and self-association in a 13 residue neuropeptide Y Y2 receptor agonist: relationship to biological activity.
    Barnham KJ; Catalfamo F; Pallaghy PK; Howlett GJ; Norton RS
    Biochim Biophys Acta; 1999 Nov; 1435(1-2):127-37. PubMed ID: 10561544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor.
    Potter EK; Barden JA; McCloskey MJ; Selbie LA; Tseng A; Herzog H; Shine J
    Eur J Pharmacol; 1994 May; 267(3):253-62. PubMed ID: 8088364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure by 2D 1H-NMR of a chimeric peptide recognized by galanin and neuropeptide Y receptors.
    Arvidsson K; Land T; Langel U; Bartfai T; Ehrenberg A
    Biochemistry; 1993 Aug; 32(30):7787-98. PubMed ID: 7688568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity analysis of N-acetyl [Leu(28,31)] NPY 24-36: a potent neuropeptide Y Y(2) receptor agonist.
    Smith-White MA; Potter EK
    Neuropeptides; 1999 Dec; 33(6):526-33. PubMed ID: 10657536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational analysis of neuropeptide Y segments by CD, NMR spectroscopy and restrained molecular dynamics.
    Gurrath M; Bisello A; Bottazzo K; Chung CW; Mammi S; Peggion E
    J Pept Sci; 1996; 2(3):176-93. PubMed ID: 9231326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilized NMR structure of human parathyroid hormone(1-34).
    Barden JA; Cuthbertson RM
    Eur J Biochem; 1993 Jul; 215(2):315-21. PubMed ID: 8344299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor.
    Rist B; Zerbe O; Ingenhoven N; Scapozza L; Peers C; Vaughan PF; McDonald RL; Wieland HA; Beck-Sickinger AG
    FEBS Lett; 1996 Sep; 394(2):169-73. PubMed ID: 8843157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR solution structure of human parathyroid hormone(1-34).
    Barden JA; Kemp BE
    Biochemistry; 1993 Jul; 32(28):7126-32. PubMed ID: 8343504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterizations of neuropeptide tyrosine (NPY) and its agonist analog [Ahx5-17]NPY by NMR and molecular modeling.
    Boulanger Y; Chen Y; Commodari F; Senécal L; Laberge AM; Fournier A; St-Pierre S
    Int J Pept Protein Res; 1995 Jan; 45(1):86-95. PubMed ID: 7775012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structure of the Y1 receptor agonist [Leu31, Pro34]NPY as determined by NMR and molecular modeling.
    Khiat A; Labelle M; Boulanger Y
    J Pept Res; 1998 Apr; 51(4):317-22. PubMed ID: 9560007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y and its C-terminal fragments acting on Y2 receptor: Raman and SERS spectroscopy studies.
    Domin H; Pięta E; Piergies N; Święch D; Kim Y; Proniewicz LM; Proniewicz E
    J Colloid Interface Sci; 2015 Jan; 437():111-118. PubMed ID: 25313473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron paramagnetic resonance backbone dynamics studies on spin-labelled neuropeptide Y analogues.
    Bettio A; Gutewort V; Pöppl A; Dinger MC; Zschörnig O; Klaus A; Toniolo C; Beck-Sickinger AG
    J Pept Sci; 2002 Dec; 8(12):671-82. PubMed ID: 12523644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridone dipeptide backbone scan to elucidate structural properties of a flexible peptide segment.
    Haack M; Enck S; Seger H; Geyer A; Beck-Sickinger AG
    J Am Chem Soc; 2008 Jul; 130(26):8326-36. PubMed ID: 18529062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilized NMR structure of the hypercalcemia of malignancy peptide PTHrP[Ala-26](1-34)amide.
    Barden JA; Kemp BE
    Biochim Biophys Acta; 1994 Oct; 1208(2):256-62. PubMed ID: 7947956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclopeptide analogs for characterization of the neuropeptide Y Y2-receptor.
    Beck-Sickinger AG; Köppen H; Hoffmann E; Gaida W; Jung G
    J Recept Res; 1993; 13(1-4):215-28. PubMed ID: 8450492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.